In this study, we observed a significant increase in the expression of the SRG FOXM1 in AAD patients, and combining the results above, we proposed that FOXM1 might play a proatherogenic role in AD development and could potentially serve as a diagnostic marker. Here, FOXM1 is linked to Alzheimer disease.